Vanda Pharmaceuticals | VNDA - Pe Prix À Revenus





Pe Changement Date
Acadia Pharmaceuticals 10.08 1.53 2026-03
Agios Pharmaceuticals 3.56 0 2026-03
Akebia Therapeutics 1.63K 1.6K 2025-12
Alnylam Pharmaceuticals 80.04 90.66 2026-03
Anika Therapeutics 47.54 27.2 2024-06
AstraZeneca 29.59 2.3 2026-03
Bristol-Myers Squibb 9.08 0.2 2026-03
Eli Lilly 40.27 0.06 2026-03
Esperion Therapeutics 129.79 129 2024-12
Halozyme Therapeutics 11.35 11.8 2026-03
J&J 24.53 0.91 2026-03
Lexicon Pharmaceuticals 12.44 4.73 2021-06
Ligand Pharmaceuticals 56.5 26.8 2026-03
Merck 16.52 2.6 2026-03
Moderna 27.22 14.51 2023-06
Novartis 21.36 3.57 2026-03
Pfizer 9.32 5.16 2026-03
PTC Therapeutics 9.98 3.25 2025-12
Puma Biotechnology 13.93 44.88 2024-06
Sanofi 11.84 0.14 2026-03
Takeda 46.52 188.53 2026-03
Teva Pharmaceutical Industries 10.07 0.04 2026-03
Vanda Pharmaceuticals 16.79 7.07 2023-06
Veracyte 24.89 20.41 2026-03